ANDA 201742, held by Sun Pharm. Temozolomide.
As of Nov 16, 2026, ANDA 201742 (Temozolomide), held by Sun Pharm, was first approved by FDA on Feb 12, 2014, with 9 approved supplements and 0 published complete response letters.
Temozolomide is an alkylating drug indicated for the treatment of adults with:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 12, 2014 | Original application | Approved |
| Temozolomide5MG · capsule;oral | Temozolomide | Rx |
| Temozolomide20MG · capsule;oral | Temozolomide | Rx |
| Temozolomide100MG · capsule;oral | Temozolomide | Rx |
| Temozolomide140MG · capsule;oral | Temozolomide | Rx |
| Temozolomide180MG · capsule;oral | Temozolomide | Rx |
| Temozolomide250MG · capsule;oral | Temozolomide | Rx |
| Jan 22, 2026 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jan 22, 2026 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jun 25, 2021 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jun 25, 2021 | Supplement 16Labeling · Standard review | Approved | None posted |
| Nov 29, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Sep 22, 2017 | Supplement 10Labeling · Standard review | Approved | None posted |
| Nov 9, 2015 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jun 10, 2015 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jan 5, 2015 | Supplement 1Labeling · Standard review | Approved | None posted |
| Feb 12, 2014 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters